Francis, A. et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 20, 473–485 (2024).Article PubMed Google Scholar Echefu, G., Stowe, I., Burka, S., Basu-Ray, I. & Kumbala, D. Pathophysiological concepts and screening of cardiovascular disease in dialysis patients. Front. Nephrol. 3, 1198560 (2023).Article PubMed PubMed Central Google Scholar Jankowski, J., Floege, J., Fliser, D., Bohm, M. & Marx, N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143, 1157–1172 (2021).Article CAS PubMed PubMed Central Google Scholar Tonelli, M. et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 380, 807–814 (2012).Article PubMed Google Scholar Wu, D. et al. Research progress on endoplasmic reticulum homeostasis in kidney diseases. Cell Death Dis. 14, 473 (2023).Article CAS PubMed PubMed Central Google Scholar Ren, J. et al. Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases. Nat. Rev. Cardiol. 18, 499–521 (2021).Article PubMed Google Scholar Marciniak, S. J., Chambers, J. E. & Ron, D. Pharmacological targeting of endoplasmic reticulum stress in disease. Nat. Rev. Drug. Discov. 21, 115–140 (2022).Article CAS PubMed Google Scholar Hetz, C. et al. Mechanisms, regulation and functions of the unfolded protein response. Nat. Rev. Mol. Cell Biol. 21, 421–438 (2020).Article CAS PubMed PubMed Central Google Scholar Cybulsky, A. V. Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases. Nat. Rev. Nephrol. 13, 681–696 (2017).Article CAS PubMed Google Scholar Gallazzini, M. et al. Endoplasmic reticulum stress and kidney dysfunction. Biol. Cell 110, 205–216 (2018).Article PubMed Google Scholar Schwarz, D. et al. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell. Mol. Life Sci. 73, 79–94 (2016).Article CAS PubMed Google Scholar Zhong, Q. et al. Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications. MedComm 4, 261 (2023).Article Google Scholar Chen, X. et al. Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. Signal. Transduct. Target. Ther. 8, 352 (2023).Article CAS PubMed PubMed Central Google Scholar Ibrahim, I. et al. GRP78: a cell’s response to stress. Life Sci. 226, 156–163 (2019).Article CAS PubMed PubMed Central Google Scholar Siwecka, N. et al. The structure, activation and signaling of IRE1 and its role in determining cell fate. Biomedicines 9, 156 (2021).Article CAS PubMed PubMed Central Google Scholar Maurel, M., Chevet, E., Tavernier, J. & Gerlo, S. Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem. Sci. 39, 245–254 (2014).Article CAS PubMed Google Scholar Hillary, R. F. & FitzGerald, U. A lifetime of stress: ATF6 in development and homeostasis. J. Biomed. Sci. 25, 48 (2018).Article PubMed PubMed Central Google Scholar Liu, Z., Lv, Y., Zhao, N., Guan, G. & Wang, J. Protein kinase R-like ER kinase and its role in endoplasmic reticulum stress-decided cell fate. Cell Death Dis. 6, e1822 (2015).Article CAS PubMed PubMed Central Google Scholar Szegezdi, E. et al. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 7, 880–885 (2006).Article CAS PubMed PubMed Central Google Scholar Verfaillie, T. et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ. 19, 1880–1891 (2012).Article CAS PubMed PubMed Central Google Scholar Wang, X. et al. Cloning of mammalian IRE1 reveals diversity in the ER stress responses. EMBO J. 19, 5708–5717 (1998).Article Google Scholar Dhanasekaran, D. et al. JNK-signaling: a multiplexing hub in programmed cell death. Genes. Cancer 8, 682–694 (2017).Article CAS PubMed PubMed Central Google Scholar Lu, T. et al. Co-downregulation of GRP78 and GRP94 induces apoptosis and inhibits migration in prostate cancer cells. Open Life Sci. 14, 384–391 (2019).Article CAS PubMed PubMed Central Google Scholar Chen, J. H., Wu, C. H. & Chiang, C. K. Therapeutic approaches targeting proteostasis in kidney disease and fibrosis. Int. J. Mol. Sci. 22, 8674 (2021).Article CAS PubMed PubMed Central Google Scholar Lebeau, P. F. et al. The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injury. J. Clin. Invest. 131, e128650 (2021).Article CAS PubMed PubMed Central Google Scholar Cybulsky, A. V. The intersecting roles of endoplasmic reticulum stress, ubiquitin-proteasome system, and autophagy in the pathogenesis of proteinuric kidney disease. Kidney Int. 84, 25–33 (2013).Article CAS PubMed Google Scholar Bek, M. F. et al. Expression and function of C/EBP homology protein (GADD153) in podocytes. Am. J. Pathol. 168, 20–32 (2006).Article CAS PubMed PubMed Central Google Scholar Markan, S. et al. Up regulation of the GRP-78 and GADD-153 and down regulation of Bcl-2 proteins in primary glomerular diseases: a possible involvement of the ER stress pathway in glomerulonephritis. Mol. Cell Biochem. 324, 131–138 (2009).Article CAS PubMed Google Scholar Chung, C. et al. Analysis of gene expression and use of connectivity mapping to identify drugs for treatment of human glomerulopathies. Front Med 13, 1122328 (2023).Article Google Scholar Ni, L., Yuan, C. & Wu, X. Endoplasmic reticulum stress in diabetic nephrology: regulation, pathological role, and therapeutic potential. Oxid. Med. Cell Longev. 2021, 7277966 (2021).Article PubMed PubMed Central Google Scholar Duangchan, T. et al. Amelioration of osteogenesis in iPSC-derived mesenchymal stem cells from osteogenesis imperfecta patients by endoplasmic reticulum stress inhibitor. Life Sci. 278, 119628 (2021).Article CAS PubMed Google Scholar Masuda, M. et al. Activating transcription factor-4 promotes mineralization in vascular smooth muscle cells. JCI Insight 1, e88646 (2016).Article PubMed PubMed Central Google Scholar Duan, X. H. et al. Activating transcription factor 4 is involved in endoplasmic reticulum stress-mediated apoptosis contributing to vascular calcification. Apoptosis 18, 1132–1144 (2013).Article CAS PubMed Google Scholar Chen, S. et al. Calcium entry via TRPC6 mediates albumin overload-induced endoplasmic reticulum stress and apoptosis in podocytes. Cell Calcium 50, 523–529 (2011).Article CAS PubMed Google Scholar Maekawa, H. et al. Stress signal network between hypoxia and ER stress in chronic kidney disease. Front. Physiol. 8, 74 (2017).Article PubMed PubMed Central Google Scholar Liu, Z. et al. ER chaperone GRP78/BiP translocates to the nucleus under stress and acts as a transcriptional regulator. Proc. Natl Acad. Sci. USA 120, e2303448120 (2023).Article CAS PubMed PubMed Central Google Scholar Ni, M., Zhang, Y. & Lee, A. S. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochem. J. 434, 181–188 (2011).Article CAS PubMed Google Scholar Sarantis, P., Koustas, E., Papadimitropoulou, A., Papavassiliou, A. G. & Karamouzis, M. V. Pancreatic ductal adenocarcinoma: treatment hurdles, tumor microenvironment and immunotherapy. World J. Gastrointest. Oncol. 12, 173–181 (2020).Article PubMed PubMed Central Google Scholar Li, Z. et al. Cell-surface GRP78 facilitates colorectal cancer cell migration and invasion. Int. J. Biochem. Cell Biol. 45, 987–994 (2013).Article CAS PubMed Google Scholar Misra, U. K., Payne, S. & Pizzo, S. V. Ligation of prostate cancer cell surface GRP78 activates a proproliferative and antiapoptotic feedback loop: a role for secreted prostate-specific antigen. J. Biol. Chem. 286, 1248–1259 (2011).Article CAS PubMed Google Scholar Gonzalez-Gronow, M. et al. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum. Cancer Res. 66, 11424–11431 (2006).Article CAS PubMed Google Scholar Lager, T. W., Conner, C., Keating, C. R., Warshaw, J. N. & Panopoulos, A. D. Cell surface GRP78 and dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling. Oncogene 40, 4050–4059 (2021).Article CAS PubMed PubMed Central Google Scholar Gonzalez-Gronow, M., Gopal, U., Austin, R. C. & Pizzo, S. V. Glucose-regulated protein (GRP78) is an important cell surface receptor for viral invasion, cancers, and neurological disorders. IUBMB Life 73, 843–854 (2021).Article CAS PubMed Google Scholar Van Krieken, R. et al. Cell surface expression of 78-kDa glucose-regulated protein (GRP78) mediates diabetic nephropathy. J. Biol. Chem. 294, 7755–7768 (2019).Article PubMed PubMed Central Google Scholar Xu, S., Sankar, S. & Neamati, N. Protein disulfide isomerase: a promising target for cancer therapy. Drug. Discov. Today 19, 222–240 (2014).Article CAS PubMed Google Scholar Dejeans, N. et al. Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence. Free. Radic. Biol. Med. 52, 993–1002 (2012).Article CAS PubMed Google Scholar Zamanian, M., Veerakumarasivam, A., Abdullah, S. & Rosli, R. Calreticulin and cancer. Pathol. Oncol. Res. 19, 149–154 (2013).Article CAS PubMed Google Scholar Trink, J. et al. Integrin β1/cell surface GRP78 complex regulates TGFβ1 and its profibrotic effects in response to high glucose. Biomedicines 10, 2247 (2022).Article CAS PubMed PubMed Central Google Scholar Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-β: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325–338 (2016).Article CAS PubMed Google Scholar Trink, J. et al. Cell surface GRP78 regulates TGFβ1-mediated profibrotic responses via TSP1 in diabetic kidney disease. Front. Pharmacol. 14, 1098321 (2023).Article CAS PubMed PubMed Central Google Scholar Tsai, Y. L. et al. Characterization and mechanism of stress-induced translocation of 78-kilodalton glucose-regulated protein (GRP78) to the cell surface. J. Biol. Chem. 290, 8049–8064 (2015).Article CAS PubMed PubMed Central Google Scholar Aitken, J. P. et al. α-2-macroglobulin in saliva is associated with glycemic control in patients with type 2 diabetes mellitus. Dis. Markers 2015, 128653 (2015).Article PubMed PubMed Central Google Scholar Ahmad, J., Singh, M. & Saleemuddin, M. A study of plasma alpha-2-macroglobulin levels in type 2 diabetic subjects with microalbuminuria. J. Assoc. Physicians India 49, 1062–1065 (2001).CAS PubMed Google Scholar Yang, A. H. & Chen, J. Y. Glomerular deposition of alpha 2-macroglobulin in glomerular diseases. Nephrol. Dial. Transpl. 12, 465–469 (1997).Article CAS Google Scholar Trink, J. et al. Activated alpha 2-macroglobulin is a novel mediator of mesangial cell profibrotic signaling in diabetic kidney disease. Biomedicines 9, 1112 (2021).Article CAS PubMed PubMed Central Google Scholar Fan, G. et al. Urine proteomics identifies biomarkers for diabetic kidney disease at different stages. Clin. Proteom. 18, 32 (2021).Article CAS Google Scholar Menon, R. et al. Single cell transcriptomics identifies focal segmental glomerulosclerosis remission endothelial biomarker. JCI Insight 5, e133267 (2020).Article PubMed PubMed Central Google Scholar Yang, L. et al. Unspliced XBP1 counteracts β-catenin to inhibit vascular calcification. Circ. Res. 130, 213–229 (2022).Article CAS PubMed Google Scholar Arhatte, M. et al. TMEM33 regulates intracellular calcium homeostasis in renal tubular epithelial cells. Nat. Commun. 10, 2024 (2019).Article PubMed PubMed Central Google Scholar De Miguel, C. et al. Endothelin receptor-specific control of endoplasmic reticulum stress and apoptosis in the kidney. Sci. Rep. 7, 43152 (2017).Article PubMed PubMed Central Google Scholar Yoshida, S. et al. Endoplasmic reticulum-associated degradation is required for nephrin maturation and kidney glomerular filtration function. J. Clin. Invest. 1, 131 (2021).Google Scholar Zhang, J. et al. Resveratrol decreases high glucose-induced apoptosis in renal tubular cells via suppressing endoplasmic reticulum stress. Mol. Med. Rep. 22, 4367–4375 (2020).PubMed PubMed Central Google Scholar Ha, K. B. et al. EW-7197 attenuates the progression of diabetic nephropathy in db/db mice through suppression of fibrogenesis and inflammation. Endocrinol. Metab. 37, 96–111 (2022).Article CAS Google Scholar Sun, Y., Zhang, T., Li, L. & Wang, J. Induction of apoptosis by hypertension via endoplasmic reticulum stress. Kidney Blood Press. Res. 40, 41–51 (2015).Article CAS PubMed Google Scholar Naiel, S., Carlisle, R. E., Lu, C., Tat, V. & Dickhout, J. G. Endoplasmic reticulum stress inhibition blunts the development of essential hypertension in the spontaneously hypertensive rat. Am. J. Physiol. Heart Circ. Physiol 316, H1214–H1223 (2019).Article CAS PubMed Google Scholar Jones, F. E. et al. ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice. Dis. Model. Mech. 9, 165–176 (2016).Article CAS PubMed PubMed Central Google Scholar Delitsikou, V. et al. Klotho regulation by albuminuria is dependent on ATF3 and endoplasmic reticulum stress. FASEB J. 34, 2087–2104 (2020).Article CAS PubMed Google Scholar Fernández-Fernández, B. et al. Albuminuria downregulation of the anti-aging factor klotho: the missing link potentially explaining the association of pathological albuminuria with premature death. Adv. Ther. 37, 62–72 (2020).Article PubMed Google Scholar Huang, D. et al. Cardiac-specific overexpression of silent information regulator 1 protects against heart and kidney deterioration in cardiorenal syndrome via inhibition of endoplasmic reticulum stress. Cell Physiol. Biochem. 46, 9–22 (2018).Article PubMed Google Scholar Byun, J. H. et al. Inhibitory antibodies against PCSK9 reduce surface CD36 and mitigate diet-induced renal lipotoxicity. Kidney360 3, 1394–1410 (2022).Article PubMed PubMed Central Google Scholar Marek, I. et al. Sex differences in the development of vascular and renal lesions in mice with a simultaneous deficiency of Apoe and the integrin chain Itga8. Biol. Sex. Differ. 8, 19 (2017).Article PubMed PubMed Central Google Scholar Chen, Y. T. et al. Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-β signaling in kidney fibroblasts. J. Clin. Invest. 131, e143645 (2021).Article CAS PubMed PubMed Central Google Scholar Jones, E. A., Shahed, A. & Shoskes, D. A. Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology 56, 346–351 (2000).Article CAS PubMed Google Scholar Ding, W., Wang, B., Zhang, M. & Gu, Y. Involvement of endoplasmic reticulum stress in uremic cardiomyopathy: protective effects of tauroursodeoxycholic acid. Cell Physiol. Biochem. 38, 141–152 (2016).Article CAS PubMed Google Scholar Feng, W. et al. Advanced oxidation protein products aggravate cardiac remodeling via cardiomyocyte apoptosis in chronic kidney disease. Am. J. Physiol. Heart Circ. Physiol 314, H475–H483 (2018).Article PubMed Google Scholar Guo, J. et al. Chronic kidney disease exacerbates myocardial ischemia reperfusion injury: role of endoplasmic reticulum stress-mediated apoptosis. Shock 49, 712–720 (2018).Article CAS PubMed Google Scholar Dai, H., Zhang, X., Yang, Z., Li, J. & Zheng, J. Effects of baicalin on blood pressure and left ventricular remodeling in rats with renovascular hypertension. Med. Sci. Monit. 23, 2939–2948 (2017).Article PubMed PubMed Central Google Scholar Mohammed-Ali, Z. et al. Endoplasmic reticulum stress inhibition attenuates hypertensive chronic kidney disease through reduction in proteinuria. Sci. Rep. 7, 41572 (2017).Article CAS PubMed PubMed Central Google Scholar Han, S. et al. Inhibition of endoplasmic reticulum stress protected DOCA-salt hypertension-induced vascular dysfunction. Vasc. Pharmacol. 113, 38–46 (2019).Article CAS Google Scholar Li, K. X., Du, Q., Wang, H. P. & Sun, H. J. Death-associated protein kinase 3 deficiency alleviates vascular calcification via AMPK-mediated inhibition of endoplasmic reticulum stress. Eur. J. Pharmacol. 852, 90–98 (2019).Article CAS PubMed Google Scholar Moellmann, J. et al. 2,8-Dihydroxyadenine-induced nephropathy causes hexosylceramide accumulation with increased mTOR signaling, reduced levels of protective SirT3 expression and impaired renal mitochondrial function. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 166825 (2024).Article CAS PubMed Google Scholar Chang, J. R. et al. Erythropoietin attenuates vascular calcification by inhibiting endoplasmic reticulum stress in rats with chronic kidney disease. Peptides 123, 170181 (2020).Article CAS PubMed Google Scholar Zhang, Y. et al. The ameliorative effect of terpinen-4-ol on ER stress-induced vascular calcification depends on SIRT1-mediated regulation of PERK acetylation. Pharmacol. Res. 170, 105629 (2021).Article CAS PubMed Google Scholar Li, C. & Chen, Y. M. Endoplasmic reticulum-associated biomarkers for molecular phenotyping of rare kidney disease. Int. J. Mol. Sci. 22, 2161 (2021).Article CAS PubMed PubMed Central Google Scholar Ma, N. et al. Levels of circulating GRP78 and CHOP in endoplasmic reticulum stress pathways in Chinese type 2 diabetic kidney disease patients. Medicine 100, e26879 (2021).Article CAS PubMed PubMed Central Google Scholar Al Zaidi M. et al. Serum levels of the endoplasmic-reticulum-stress chaperone GRP78 are associated with inflammation, identify patients with coronary artery disease and predict mortality. Eur. Heart J. 44, ehad655.1196 (2023).Article Google Scholar Crane, E. D. et al. Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions. JCI Insight 3, e99363 (2018).Article PubMed PubMed Central Google Scholar Kim, Y. et al. Mesencephalic astrocyte-derived neurotrophic factor as a urine biomarker for endoplasmic reticulum stress-related kidney diseases. J. Am. Soc. Nephrol. 10, 2974–2982 (2016).Article Google Scholar Tousson-Abdouelazm, N. et al. Urinary ERdj3 and mesencephalic astrocyte-derived neutrophic factor identify endoplasmic reticulum stress in glomerular disease. Lab. Invest. 100, 945–958 (2020).Article Google Scholar Nasr, S. H. et al. Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients. Kidney Int. 95, 1269–1272 (2019).Article CAS PubMed Google Scholar Dihazi, H. et al. Secretion of ERP57 is important for extracellular matrix accumulation and progression of renal fibrosis, and is an early sign of disease onset. J. Cell Sci. 126, 3649–3663 (2013).CAS PubMed Google Scholar Kim, Y. et al. Elevated urinary CRELD2 is associated with endoplasmic reticulum stress-mediated kidney disease. JCI Insight 2, e92896 (2017).Article PubMed PubMed Central Google Scholar Torene, R. I. et al. Systematic analysis of variants escaping nonsense-mediated decay uncovers candidate Mendelian diseases. Am. J. Hum. Genet. 111, 70–81 (2024).Article CAS PubMed Google Scholar Consolato, F. et al. α-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response. Mol. Genet. Metab. Rep. 33, 100926 (2022).CAS PubMed PubMed Central Google Scholar McCafferty, E. H. & Scott, L. J. Migalastat: a review in Fabry disease. Drugs 79, 543–554 (2019).Article CAS PubMed PubMed Central Google Scholar Yam, G. H., Bosshard, N., Zuber, C., Steinmann, B. & Roth, J. Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants. Am. J. Physiol. Cell Physiol 290, C1076–C1082 (2006).Article CAS PubMed Google Scholar Yam, G. H., Zuber, C. & Roth, J. A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder. FASEB J. 19, 12–18 (2005).Article CAS PubMed Google Scholar Hughes, D. A. et al. Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. J. Med. Genet. 54, 288–296 (2017).Article CAS PubMed Google Scholar Olinger, E. et al. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1. Kidney Int. 98, 717–731 (2020).Article CAS PubMed Google Scholar Scolari, F., Izzi, C. & Ghiggeri, G. M. Uromodulin: from monogenic to multifactorial diseases. Nephrol. Dial. Transpl. 30, 1250–1256 (2015).Article CAS Google Scholar Devuyst, O. et al. Autosomal dominant tubulointerstitial kidney disease. Nat. Rev. Dis. Primers 5, 60 (2019).Article PubMed Google Scholar Olinger, E. et al. An intermediate-effect size variant in UMOD confers risk for chronic kidney disease. Proc. Natl Acad. Sci. USA 119, e2114734119 (2022).Article CAS PubMed Central Google Scholar Liu, Y., Goldfarb, D. S., El-Achkar, T. M., Lieske, J. C. & Wu, X. R. Tamm-Horsfall protein/uromodulin deficiency elicits tubular compensatory responses leading to hypertension and hyperuricemia. Am. J. Physiol. Renal Physiol 314, F1062–F1076 (2018).Article CAS PubMed PubMed Central Google Scholar Schaeffer, C., Merella, S., Pasqualetto, E., Lazarevic, D. & Rampoldi, L. Mutant uromodulin expression leads to altered homeostasis of the endoplasmic reticulum and activates the unfolded protein response. PLoS ONE 12, e0175970 (2017).Article PubMed PubMed Central Google Scholar Johnson, B. et al. Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis. J. Clin. Invest. 127, 3954–3969 (2017).Article PubMed PubMed Central Google Scholar Kemter, E., Frohlich, T., Arnold, G. J., Wolf, E. & Wanke, R. Mitochondrial dysregulation secondary to endoplasmic reticulum stress in autosomal dominant tubulointerstitial kidney disease — UMOD (ADTKD-UMOD). Sci. Rep. 7, 42970 (2017).Article CAS PubMed PubMed Central Google Scholar Kim, Y. et al. MANF stimulates autophagy and restores mitochondrial homeostasis to treat autosomal dominant tubulointerstitial kidney disease in mice. Nat. Commun. 14, 6493 (2023).Article CAS PubMed PubMed Central Google Scholar Amatruda, J. G. et al. Biomarkers of kidney tubule disease and risk of end-stage kidney disease in persons with diabetes and CKD. Kidney Int. Rep. 7, 1514–1523 (2022).Article PubMed PubMed Central Google Scholar Lanktree, M. B. et al. A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulation. Kidney Int. 104, 1170–1184 (2023).Article CAS PubMed Google Scholar Turner, M. & Staplin, N. UMOD-ulating CKD risk: untangling the relationship between urinary uromodulin, blood pressure, and kidney disease. Kidney Int. 100, 1168–1170 (2021).Article CAS PubMed Google Scholar Kim, Y. et al. Ultrabright plasmonic fluor nanolabel-enabled detection of a urinary ER stress biomarker in autosomal dominant tubulointerstitial kidney disease. Am. J. Physiol. Renal Physiol 321, F236–F244 (2021).Article CAS PubMed PubMed Central Google Scholar Daga, S. et al. The 2019 and 2021 international workshops on Alport syndrome. Eur. J. Hum. Genet. 30, 507–516 (2022).Article CAS PubMed PubMed Central Google Scholar Papazachariou, L. et al. Frequency of COL4A3/COL4A4 mutations amongst families segregating glomerular microscopic hematuria and evidence for activation of the unfolded protein response. Focal and segmental glomerulosclerosis is a frequent development during ageing. PLoS ONE 9, e115015 (2014).Article PubMed PubMed Central Google Scholar Wang, D. et al. The chemical chaperone, PBA, reduces ER stress and autophagy and increases collagen IV alpha5 expression in cultured fibroblasts from men with X-linked Alport syndrome and missense mutations. Kidney Int. Rep. 2, 739–748 (2017).Article PubMed PubMed Central Google Scholar Hirayama, R. et al. iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome. Commun. Biol. 28, 854 (2023).Article Google Scholar Park, S. J., Kim, Y. & Chen, Y. M. Endoplasmic reticulum stress and monogenic kidney diseases in precision nephrology. Pediatr. Nephrol. 34, 1493–1500 (2019).Article PubMed Google Scholar Kopp, J. B. et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 22, 2129–2137 (2011).Article CAS PubMed PubMed Central Google Scholar Egbuna, O. et al. Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants. N. Engl. J. Med. 388, 969–979 (2023).Article CAS PubMed Google Scholar Madhavan, S. et al. Variant upon variant: kidney-disease risk associated with APOL1 G2 genetic variants is abrogated by the APOL1 p.N264K variant. Kidney Int. 24, 325–329 (2024).Google Scholar Wen, H. et al. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress. Biosci. Rep. 38, BSR20171713 (2018).Article PubMed PubMed Central Google Scholar Mitrotti, A. et al. Hidden genetics behind glomerular scars: an opportunity to understand the heterogeneity of focal segmental glomerulosclerosis? Pediatr. Nephrol. 6, 1685–1707 (2024).Article Google Scholar Kuzmuk, V. et al. A small molecule chaperone rescues keratin-8 mediated trafficking of misfolded podocin to correct genetic nephrotic syndrome. Kidney Int. 105, 744–758 (2024).Article CAS PubMed Google Scholar Navarro-Betancourt, J. R. et al. Role of IRE1α in podocyte proteostasis and mitochondrial health. Cell Death Discov. 6, 128 (2020).Article CAS PubMed PubMed Central Google Scholar Achari, G. et al. Effect of temperature on the action of calcium on isolated rabbit ileum. Jpn J. Pharmacol. 18, 418–420 (1968).Article CAS PubMed Google Scholar Serrano-Perez, M. C. et al. Endoplasmic reticulum-retained podocin mutants are massively degraded by the proteasome. J. Biol. Chem. 293, 4122–4133 (2018).Article CAS PubMed PubMed Central Google Scholar Yan, Z. et al. A single-center analysis of genotype-phenotype characteristics of Chinese patients with autosomal dominant polycystic kidney disease by targeted exome sequencing. Front. Genet. 13, 934463 (2022).Article CAS PubMed PubMed Central Google Scholar Cornec-Le Gall, E. et al. Type of PKD1 mutation influences renal outcome in ADPKD. J. Am. Soc. Nephrol. 24, 1006–1013 (2013).Article PubMed PubMed Central Google Scholar Lanktree, M. B., Haghighi, A., di Bari, I., Song, X. & Pei, Y. Insights into autosomal dominant polycystic kidney disease from genetic studies. Clin. J. Am. Soc. Nephrol. 16, 790–799 (2021).Article CAS PubMed PubMed Central Google Scholar Ishikawa, Y. et al. Spliced XBP1 rescues renal interstitial inflammation due to loss of Sec63 in collecting ducts. J. Am. Soc. Nephrol. 30, 443–459 (2019).Article CAS PubMed PubMed Central Google Scholar Fedeles, S. V. et al. Sec63 and Xbp1 regulate IRE1α activity and polycystic disease severity. J. Clin. Invest. 125, 1955–1967 (2015).Article PubMed PubMed Central Google Scholar Zhou, X. et al. PKD2 deficiency suppresses amino acid biosynthesis in ADPKD by impairing the PERK-TBL2-eIF2a-ATF4 pathway. Biochem. Biophys. Res. Commun. 561, 73–79 (2021).Article CAS PubMed Google Scholar Westland, R. & Sanna-Cherchi, S. Recessive mutations in CAKUT and VACTERL association. Kidney Int. 85, 1253–1255 (2014).Article CAS PubMed Google Scholar Kolvenbach, C. M., Shril, S. & Hildebrandt, F. The genetics and pathogenesis of CAKUT. Nat. Rev. Nephrol. 19, 709–720 (2023).Article CAS PubMed Google Scholar Saisawat, P. et al. Whole-exome resequencing reveals recessive mutations in TRAP1 in individuals with CAKUT and VACTERL association. Kidney Int. 85, 1310–1317 (2014).Article CAS PubMed Google Scholar Deeb A., Al-Zidgali F., Ofoegbu B. N. Multicystic dysplastic kidney: a new association of Wolcott-Rallison syndrome. Endocrinol. Diabetes Metab. Case Rep. 2017, 17-0090 (2017).PubMed PubMed Central Google Scholar Cameron, N. E. Role of endoplasmic reticulum stress in diabetic neuropathy. Diabetes 62, 696–697 (2013).Article CAS PubMed PubMed Central Google Scholar Lee, E. S. et al. Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model. Nephrol. Dial. Transpl. 31, 391–400 (2016).Article CAS Google Scholar Inagi, R. et al. Involvement of endoplasmic reticulum (ER) stress in podocyte injury induced by excessive protein accumulation. Kidney Int. 68, 2639–2650 (2005).Article CAS PubMed Google Scholar Sieber, J. et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am. J. Physiol. Renal Physiol 299, F821–F829 (2010).Article CAS PubMed PubMed Central Google Scholar Madhusudhan, T. et al. Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy. Nat. Commun. 6, 6496 (2015).Article CAS PubMed Google Scholar Huang, Y. et al. High-expression of FABP4 in tubules is a risk factor for poor prognosis in DKD patients. Curr. Med. Chem. 31, 3436–3446 (2024).Article CAS PubMed Google Scholar Yao, F. et al. Fatty acid-binding protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy. Mol. Cell Endocrinol. 15, 232–242 (2015).Article Google Scholar Xie, Y. et al. Reticulon-1A mediates diabetic kidney disease progression through endoplasmic reticulum-mitochondrial contacts in tubular epithelial cells. Kidney Int. 102, 293–306 (2022).Article CAS PubMed PubMed Central Google Scholar Shahzed, K. et al. CHOP-ASO ameliorates glomerular and tubular damage on top of ACE inhibition in diabetic kidney disease. J. Am. Soc. Nephrol. 32, 3066–3079 (2021).Article Google Scholar Wang, M. et al. Beneficial effect of ER stress preconditioning in protection against FFA-induced adipocyte inflammation via XBP1 in 3T3-L1 adipocytes. Mol. Cell Biochem. 463, 45–55 (2020).Article CAS PubMed Google Scholar Chen, B. et al. Epigallocatechin-3-gallate protects against cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis. Exp. Biol. Med. 240, 1513–1519 (2015).Article CAS Google Scholar Basseri, S., Lhotak, S., Sharma, A. M. & Austin, R. C. The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J. Lipid Res. 50, 2486–2501 (2009).Article CAS PubMed PubMed Central Google Scholar Vang, S., Longley, K., Steer, C. J. & Low, W. C. The unexpected uses of urso- and tauroursodeoxycholic acid in the treatment of non-liver diseases. Glob. Adv. Health Med. 3, 58–69 (2014).Article PubMed PubMed Central Google Scholar Weaver, F. E. et al. 4-Phenylbutyric acid mitigates ER stress-induced neurodegeneration in the spinal cords of a GM2 gangliosidosis mouse model. Hum. Mol. Genet. 34, 32–46 (2024).Article PubMed Central Google Scholar Bonnemaison, M. L., Marks-Nelson, E. S. & Boesen, E. I. Sodium 4-phenylbutyrate treatment protects against renal injury in NZBWF1 mice. Clin. Sci. 133, 167–180 (2019).Article CAS Google Scholar Liu, S. H. et al. Chemical chaperone 4-phenylbutyrate protects against the endoplasmic reticulum stress-mediated renal fibrosis in vivo and in vitro. Oncotarget 7, 22116–22127 (2016).Article PubMed PubMed Central Google Scholar Cao, A. L. et al. Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy. Lab. Invest. 96, 610–622 (2016).Article CAS PubMed Google Scholar Carlisle, R. E. et al. 4-Phenylbutyrate inhibits tunicamycin-induced acute kidney injury via CHOP/GADD153 repression. PLoS ONE 9, e84663 (2014).Article PubMed PubMed Central Google Scholar Yum, V. et al. Endoplasmic reticulum stress inhibition limits the progression of chronic kidney disease in the Dahl salt-sensitive rat. Am. J. Physiol. Renal Physiol 312, F230–F244 (2017).Article CAS PubMed Google Scholar Shu, S. et al. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease. EBioMedicine 37, 269–280 (2018).Article PubMed PubMed Central Google Scholar Jeon, J. H. et al. Chemical chaperones to inhibit endoplasmic reticulum stress: implications in diseases. Drug. Des. Devel Ther. 16, 4385–4397 (2022).Article CAS PubMed PubMed Central Google Scholar Junjappa, R. P., Patil, P., Bhattarai, K. R., Kim, H. R. & Chae, H. J. IRE1α implications in endoplasmic reticulum stress-mediated development and pathogenesis of autoimmune diseases. Front. Immunol. 9, 1289 (2018).Article PubMed PubMed Central Google Scholar Wang, N. et al. Resveratrol protects against early polymicrobial sepsis-induced acute kidney injury through inhibiting endoplasmic reticulum stress-activated NF-κB pathway. Oncotarget 8, 36449–36461 (2017).Article PubMed PubMed Central Google Scholar Yao, W. et al. IRE1α siRNA relieves endoplasmic reticulum stress-induced apoptosis and alleviates diabetic peripheral neuropathy in vivo and in vitro. Sci. Rep. 8, 2579 (2018).Article PubMed PubMed Central Google Scholar The E-KCG. et al. Empagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 388, 117–127 (2023).Article Google Scholar Sun, H. L. et al. ACE-inhibitor suppresses the apoptosis induced by endoplasmic reticulum stress in renal tubular in experimental diabetic rats. Exp. Clin. Endocrinol. Diabetes 117, 336–344 (2009).Article CAS PubMed Google Scholar Wang, W. et al. Protective effects of aliskiren and valsartan in mice with diabetic nephropathy. J. Renin Angiotensin Aldosterone Syst. 15, 384–395 (2014).Article CAS PubMed Google Scholar Hartner, A. et al. Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of endoplasmic reticulum stress. Biochim. Biophys. Acta 1842, 558–565 (2014).Article CAS PubMed Google Scholar Shibusawa, R. et al. Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death. Sci. Rep. 9, 9887 (2019).Article PubMed PubMed Central Google Scholar Yuan, Y. et al. The roles of oxidative stress, endoplasmic reticulum stress, and autophagy in aldosterone/mineralocorticoid receptor-induced podocyte injury. Lab. Invest. 95, 1374–1386 (2015).Article CAS PubMed Google Scholar Tangri, N. & Ferguson, T. W. Role of artificial intelligence in the diagnosis and management of kidney disease: applications to chronic kidney disease and acute kidney injury. Curr. Opin. Nephrol. Hypertens. 31, 283–287 (2022).Article CAS PubMed Google Scholar Noh, M. R., Kim, J. I., Han, S. J., Lee, T. J. & Park, K. M. C/EBP homologous protein (CHOP) gene deficiency attenuates renal ischemia/reperfusion injury in mice. Biochim. Biophys. Acta 1852, 1895–1901 (2015).Article CAS PubMed Google Scholar Rubenstein, R. C. & Zeitlin, P. L. A pilot clinical trial of oral sodium 4-phenylbutyrate (buphenyl) in ΔF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Am. J. Respir. Crit. Care Med. 157, 484–490 (1998).Article CAS PubMed Google Scholar Elia, A. E. et al. Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. Eur. J. Neurol. 1, 45–52 (2016).Article Google Scholar Sagel, S. C. et al. Clinical effectiveness of lumacaftor/ivacaftor in patients with cystic fibrosis homozygous for F508del-CFTR. a clinical trial. Ann. Am. Thorac. Soc. 18, 75–83 (2021).Article PubMed PubMed Central Google Scholar Goralski, J. L. et al. Phase 3 open-label clinical trial of elexacaftor/tezacaftor/ivacaftor in children aged 2-5 years with cystic fibrosis and at least one F508del allele. Am. J. Respir. Crit. Care Med. 208, 59–67 (2023).Article CAS PubMed PubMed Central Google Scholar Maurer, M. S. et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N. Engl. J. Med. 379, 1007–1016 (2018).Article CAS PubMed Google Scholar